Results 191 to 200 of about 9,592 (241)

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications [PDF]

core   +1 more source

Viral hepatitis after liver transplantation: A brief overview. [PDF]

World J Virol
Praharaj DL, Giri S, Anand AC, Mallick B, Nath P, Sahu SK, Pattnaik B, Acharya SK, Chawla YK.   +8 more
europepmc   +1 more source

Drug-Target Interaction Prediction via Dual-Interaction Fusion. [PDF]

Molecules
Li X, Li Z, Wei B, Zeng Y.
europepmc   +1 more source

Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report. [PDF]

Pathogens
Talarek E, Aniszewska M, Dobrzeniecka A, Kmiotek J, Pokorska-Śpiewak M.   +4 more
europepmc   +1 more source

High efficacy and safety of direct-acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam. [PDF]

Pharmacol Res Perspect
Vo TD, Bui VTT, Lam HT, Bui QTH.
europepmc   +1 more source

Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India. [PDF]

BMC Infect Dis
Dutta S, Nath S, Das R, Bakshi S, Majumdar M, Ghosh A, Baskey U, Chowdhury PK, Sadhukhan PC.   +8 more
europepmc   +1 more source

Alternative Pharmaceutical Innovation Models in Competitive Markets: A Collaborative Approach to Develop a Novel Drug for Hepatitis C. [PDF]

Trop Med Infect Dis
Vieira M, Slovenski I, Large K, Alonso Ruiz A, Moon S.   +4 more
europepmc   +1 more source

Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors. [PDF]

Sci Rep
Toyodome A, Mawatari S, Eguchi H, Takeda M, Kumagai K, Taniyama O, Ijuin S, Sakae H, Tabu K, Oda K, Ikeda M, Ido A.   +11 more
europepmc   +1 more source

Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation. [PDF]

J Virol
Matsui C, Yuliandari P, Deng L, Abe T, Shoji I.   +4 more
europepmc   +1 more source

Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study. [PDF]

Front Med (Lausanne)
Kashani M, Karimi M, Sharifi Rayeni A, Azizi Nadian MA, Mortezazadeh M, Parsaei A, Abolghasemi N, Shirsalimi N, Mofidi A, Seyyed Mahmoudi ST.   +9 more
europepmc   +1 more source